President

Blake Tomkinson, PhD, MBA, currently VP of Clinical Development at Kura Oncology, has over 25 years’ experience in the biotechnology and pharmaceutical industry with research and clinical development experience in virology, immunology and oncology.  Blake has extensive expertise as a project leader, leading the clinical development of several small molecule, monoclonal antibody oncology and peptide compounds at OSI/Gilead, Sanofi and EMD Serono/Merck KGaA. Blake also has business development search and evaluation expertise in oncology with Sanofi and Takeda Pharmaceuticals as an external consultant.  Blake received his PhD in Immunology from the University of Massachusetts Medical School and did his post-doctoral research in molecular biology at Brigham and Women’s Hospital and Harvard Medical School.  Blake received his MBA from the University of Colorado, Denver.

Secretary

Heather Vital has over 15 years of experience in biological sciences and drug development and commercialization. She is currently the Senior Director, Portfolio Strategy & Operations at Relay Therapeutics, a clinical-stage precision medicines company based on the dynamics of protein motion for oncology and genetic diseases. She previously was the Senior Director, Program Leadership at Deciphera Pharmaceuticals, a company focused on development of tyrosine kinase inhibitors for treatment of a variety of cancers. As the Program Lead, she was responsible for coordinating cross-functional operations and articulation of long-term strategy to deliver potential treatments to patients. Heather’s prior experience spans research and commercialization efforts across a large portfolio of programs and disease areas at Biogen and project management at Clarkston Consulting. Heather received her MBA and SM in Biological Sciences through the Biomedical Enterprise Program at MIT Sloan School of Management and the Harvard-MIT Division of Health, Sciences and Technology.

Treasurer

Donald Tomkinson is a senior level executive with 40 years proven experience in General Management, Finance, Sales, Customer Service, and Engineering at leading reseller, manufacturing and software organizations.  Donald has an established track record assessing capabilities, developing solutions and executing plans to improve company performance in virtually every functional area. For the past 15 years, Donald has been the owner/GM of company that provides custom labeling, software and financial accounting services including performing CFO tasks at a large customer since 2010.  Previously, Donald was also treasurer of Casco Village Church and Non-Profit Reusable Resources of Attleboro, as well as board member of Framework Technologies, Inc.

Vice-President

Kaleigh Tomkinson, is a graduate of University of New England College of Osteopathic Medicine with a Doctor of Osteopathic Medicine (DO) degree. She has medical knowledge in general pediatric medicine, as well as hematology and oncology. Before pursing medical school, Kaleigh completed her undergraduate studies from Worcester Polytechnic Institute and then Masters of Biomedical Sciences at Tufts University School of Medicine.  While finishing her Masters degree, Kaleigh worked at Microbiotix Inc, a biotech focused on finding therapies for infectious diseases. Kaleigh also worked at CRISPR Therapeutics as a critical team member in the development of their first gene therapy in patients with Beta-Thalassemia, which initiated the first in human clinical trial in March 2018.  She is currently a first-year resident in the pediatric program at Tufts Children’s Hospital.